TY  -  JOUR
AU  -  Giuliani, Jacopo
AU  -  Bonetti, Andrea
T1  -  Alectinib in first-line treatment for advanced
anaplastic lymphoma kinase mutation-positive (alk+)
non-small cell lung cancer (NSCLC): a cost-effective change
PY  -  2021
Y1  -  2021-06-01
DO  -  10.1701/3620.36032
JO  -  Recenti Progressi in Medicina
JA  -  Recenti Prog Med
VL  -  112
IS  -  6
SP  -  472
EP  -  475
PB  -  Il Pensiero Scientifico Editore
SN  -  2038-1840
Y2  -  2026/04/23
UR  -  http://dx.doi.org/10.1701/3620.36032
ER  -